fingolimod hydrochloride has been researched along with Central Nervous System Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alassiri, A; Algahtani, H; Shirah, B | 1 |
1 review(s) available for fingolimod hydrochloride and Central Nervous System Neoplasm
| Article | Year |
|---|---|
Tumefactive demyelinating lesions: A comprehensive review.
Topics: Adrenal Cortex Hormones; Brain Neoplasms; Central Nervous System Neoplasms; Demyelinating Autoimmune Diseases, CNS; Deprescriptions; Diagnosis, Differential; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Sclerosis; Natalizumab; Plasma Exchange; Risk Factors | 2017 |